Envisia Therapeutics today announced that it will present initial findings from its ENV515 program at the Glaucoma 360 New Horizons Forum on Friday, February 7, 2014 at the Palace Hotel in San Francisco. The presentation marks the company’s first data presentation since its foundation last November. The conference, presented by Glaucoma Research Foundation (GRF), provides a forum for unique exchange on research innovation and advances in glaucoma treatment. Globally, glaucoma is a leading cause of preventable blindness.
Help employers find you! Check out all the jobs and post your resume.
